Compare APAM & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | APAM | HTFL |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2011 | 2025 |
| Metric | APAM | HTFL |
|---|---|---|
| Price | $33.72 | $56.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $35.25 | ★ $47.22 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 10-27-2026 | 11-12-2026 |
| Dividend Yield | ★ 11.71% | N/A |
| EPS Growth | 10.66 | ★ 82.37 |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $1,196,688,000.00 | $176,034,000.00 |
| Revenue This Year | $2.69 | $41.33 |
| Revenue Next Year | $0.56 | $24.23 |
| P/E Ratio | $18.12 | ★ N/A |
| Revenue Growth | 7.63 | ★ 39.92 |
| 52 Week Low | $30.86 | $20.13 |
| 52 Week High | $46.53 | $57.25 |
| Indicator | APAM | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 44.25 | 66.26 |
| Support Level | $30.86 | $46.46 |
| Resistance Level | $38.32 | N/A |
| Average True Range (ATR) | 1.08 | 3.08 |
| MACD | 0.31 | 0.52 |
| Stochastic Oscillator | 67.63 | 90.44 |
Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.